Mark Marchionni
24Patents
10h-index
20Co-inventors
75Inventor score
Filing activity: Apr 1, 1992 → Aug 29, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6635249B1 | Methods for treating congestive heart failure | Human Necessities | 49 | Expired |
| US5716930A | Glial growth factors | Chemistry; Metallurgy | 48 | Expired |
| US6444642B1 | Methods of increasing myotube formation or survival or muscle cell mitogenesis, differentiation or survival using a neuregulin | Human Necessities | 36 | Expired |
| US8114838B2 | Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 | Physics | 35 | Expired |
| US7037888B1 | Methods for treating muscle diseases and disorders | Human Necessities | 29 | Expired |
| US6750196B1 | Methods of treating disorders of the eye | Chemistry; Metallurgy | 29 | Expired |
| US6087323A | Use of neuregulins as modulators of cellular communication | Human Necessities | 27 | Expired |
| US5876973A | Method for making antibodies which specifically bind to glial growth factors | Human Necessities | 17 | Expired |
| US7115554B1 | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III | Human Necessities | 14 | Expired |
| US8394761B2 | Methods for treating congestive heart failure | Human Necessities | 10 | Active |
| US7662772B2 | Methods for treating congestive heart failure | Human Necessities | 9 | Expired |
| US7384756B1 | Methods for treating muscle diseases and disorders | Human Necessities | 8 | Expired |
| US7319019B1 | Glial mitogenic factors lacking an N-terminal signal sequence | Chemistry; Metallurgy | 7 | Expired |
| US8076283B2 | Methods for treating congestive heart failure | Human Necessities | 5 | Active |
| US6890751B2 | NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | Physics | 4 | Expired |
| US8026213B2 | Methods for treating muscle diseases and disorders | Human Necessities | 3 | Active |
| US7968678B2 | Glial mitogenic factors, their preparation and use | Chemistry; Metallurgy | 1 | Active |
| US10065999B2 | Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 | Physics | 1 | Active |
| US7718606B2 | Methods for treating muscle diseases and disorders | Human Necessities | 1 | Active |
| US6872698B2 | Methods for treating neurological injuries and disorders | Human Necessities | 1 | Expired |
| US10232016B2 | Methods for treating congestive heart failure | Human Necessities | 1 | Active |
| US6204241A | Method for treating nervous system pathophysiologies using glial growth factors | Chemistry; Metallurgy | 0 | Expired |
| US6232061A | Homology cloning | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10717775B2 | Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.